Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - AstraZenca; Boston Scientific Corporation; Medtronic; Bard Medical; Cook Medical
- Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; Boston Scientific Corporation; Medtronic